Vikas Bali

Employment

• Kusum Healthcare Private Limited Manager
  2021 - Present
• Kusum Healthcare Pvt Ltd Deputy Manager
  2018 - 2021
• Sun Pharmaceutical Industries Ltd R&D Centre Research Manager
  2017 - 2018
• Jubilant Life Sciences (India) Research Scientist (Level 9A)
  2014 - 2017
• Jubilant Life Sciences (India) Research Scientist (Level 9)
  2011 - 2014
• Rajiv Academy for Pharmacy Assistant Professor
  2010 - 2011

Education

• Jamia Hamdard Doctor of Philosophy
  2006 - 2010
• Jamia Hamdard Masters
  2004 - 2006
• Jamia Hamdard Bachelor of Science
  2001 - 2004

Projects & Funding

Projects & funding information is unavailable.

Publications (16)

• Comparative evaluation of porous versus nonporous mucoadhesive films as buccal delivery system of glibenclamide
  AAPS PharmSciTech 2013 DOI: 10.1208/s12249-013-0014-6
  +Save
• Nanomedicines for nasal drug delivery
  Patenting Nanomedicines: Legal Aspects, Intellectual Property and Grant Opportunities 2013 DOI: 10.1007/978-3-642-29265-1_8
  +Save
• Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan
  International Journal of Pharmaceutics 2012 DOI: 10.1016/j.ijpharm.2012.01.027
  +Save
• Bilayered transmucosal drug delivery system of pravastatin sodium: Statistical optimization, in vitro, ex vivo, in vivo and stability assessment
  Drug Delivery 2012 DOI: 10.3109/10717544.2011.644348
  +Save
• Product development studies on surface-adsorbed nanoemulsion of olmesartan medoxomil as a capsular dosage form
  AAPS PharmSciTech 2012 DOI: 10.1208/s12249-012-9847-7
  +Save
• Ultra-adaptable nanovesicular systems: A carrier for systemic delivery of therapeutic agents
  Drug Discovery Today 2012 DOI: 10.1016/j.drudis.2012.06.013
  +Save
• Development and validation of a novel spectrophotometric analytical method for the determination of olmesartan medoxomil in pharmaceutical formulations
  International Journal of Pharmacy and Pharmaceutical Sciences 2011
  +Save
• Nanocarrier for the enhanced bioavailability of a cardiovascular agent: In vitro, pharmacodynamic, pharmacokinetic and stability assessment
  International Journal of Pharmaceutics 2011 DOI: 10.1016/j.ijpharm.2010.10.018
  +Save
• Novel microbially triggered colon specific delivery system of 5-Fluorouracil: Statistical optimization, in vitro, in vivo, cytotoxic and stability assessment
  International Journal of Pharmaceutics 2011 DOI: 10.1016/j.ijpharm.2011.03.057
  +Save
• Therapeutic applications of nanoemulsion based drug delivery systems:A review of patents in last two decades
  Recent Patents on Drug Delivery and Formulation 2011 DOI: 10.2174/187221111795471427
  +Save